🇺🇸 FDA
Patent

US 7196205

Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

granted A61KA61K31/4025A61P

Quick answer

US patent 7196205 (Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4025, A61P, A61P1/16, A61P17/02